Extension arm facilitated PEGylation of hemoglobin: Correlation of the properties with the extent of PEGylation

被引:38
作者
Li, Dongxia
Manjula, Belur N.
Acharya, A. Seetharama
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA
关键词
blood substitute; extension arm facilitated PEGylation; hemoglobin; maleimide chemistry; PEGylation;
D O I
10.1007/s10930-006-9010-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human hemoglobin (Hb) conjugated with six copies of PEG-5K is nonhypertensive. The hexaPEGylated Hb exhibits molecular size homogeneity in spite of the chemical heterogeneity with respect to the sites of conjugation (Manjula et al., 2005). In the present study, Hb conjugated with an average of 4, 6, 8 and 10 copies of PEG-5K chains have been generated using the extension arm facilitated PEGylation protocol. Except for the tetraPEGylated Hb, all the other products exhibit molecular size homogeneity. The molecular, colligative and functional properties of PEG-Hb conjugates have been correlated with the extent of PEGylation. The results imply that six copies of PEG-5K chains are accommodated on Hb without significant crowding on the molecular surface. As more copies of PEG-5K chains are conjugated to form octa and deca PEGylated Hb, the PEG-chains conjugated appear to undergo transition from a mushroom (compact) to a brush-like conformation (extended conformation) with a concomitant decrease in the propensity of the molecule to transition from oxy to deoxy conformation in the presence of allosteric effectors. The viscosity and the colloidal osmotic pressure of Hb increase with the number of the PEG-chains conjugated in an exponential fashion. The composition of the PEGylated Hb generated appears to be controlled by (i) high reactivity of thiol groups of the extension arms on Hb with maleimide-PEG, (ii) increase in the viscosity of the reaction mixture as the level of PEGylation increases and (iii) increased resistance induced by the PEG-shell of PEGylated Hb to accommodate more PEG-chains as the level of PEGylation increases. Potential implications of extent of PEGylation on the oxygen delivery by PEG-Hb conjugate in vivo have been discussed.
引用
收藏
页码:263 / 274
页数:12
相关论文
共 29 条
[1]  
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
[2]  
ACHARYA AS, 2006, BLOOD SUBSTITUTES, P460
[3]  
ACHARYA AS, 1996, Patent No. 5585484
[4]   Enhanced molecular volume of conservatively pegylated Hb:: (SP-PEG5K)6-HbA is non-hypertensive [J].
Acharya, SA ;
Friedman, JM ;
Manjula, BN ;
Intaglietta, M ;
Tsai, AG ;
Winslow, RM ;
Malavalli, A ;
Vandegriff, K ;
Smith, PK .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2005, 33 (03) :239-255
[5]   DETERMINATION OF REACTIVE SULFHYDRYL GROUPS IN HEME PROTEINS WITH 4,4'-DIPYRIDINEDISULFIDE [J].
AMPULSKI, RS ;
AYERS, VE ;
MORELL, SA .
ANALYTICAL BIOCHEMISTRY, 1969, 32 (01) :163-&
[6]   Polyethylene glycol-conjugated pharmaceutical proteins [J].
Bailon, P ;
Berthold, W .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08) :352-356
[7]   Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C [J].
Bailon, P ;
Palleroni, A ;
Schaffer, CA ;
Spence, CL ;
Fung, WJ ;
Porter, JE ;
Ehrlich, GK ;
Pan, W ;
Xu, ZX ;
Modi, MW ;
Farid, A ;
Berthold, W .
BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :195-202
[8]   Microvascular PO2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamber [J].
Cabrales, P ;
Kanika, ND ;
Manjula, BN ;
Tsai, AG ;
Acharya, SA ;
Intaglietta, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (04) :H1609-H1617
[9]   Future prospects for artificial blood [J].
Chang, TMS .
TRENDS IN BIOTECHNOLOGY, 1999, 17 (02) :61-67
[10]   The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models [J].
Conover, CD ;
Linberg, R ;
Shum, KL ;
Shorr, RGL .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1999, 27 (02) :93-107